White Papers | eNewsletter


Blogs


RSS - Blogs
 

Poll Question:

 


SAMHSA awards grant to help physicians treat opioid addictions

 
(6/10/2010)
Press Release

Rockville, MD — The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding the Physician Clinical Support System for the Treatment of Substance Use Disorders (PCSS) cooperative agreement grant to the American Academy of Addiction Psychiatry based in Providence, Rhode Island.  The grant is projected to provide up to a total of $1.5 million in funding over the course of three years.
 
The grant program is intended to further develop the current DATA Physician Clinical Support System.  The system is used to assist physicians who are treating patients dependent on heroin or prescription opioid drugs with FDA-approved products containing buprenorphine. 
 
To help instruct physicians the American Academy of Addiction Psychiatry plans to implement a four-hour self-training and examination program on state-of-the-art approaches to opioid addiction assessment and treatment.  The program also involves a follow-up four-hour, one-on-one training session with an experienced instructor/practitioner who will mentor their trainees on an ongoing basis.
 
“This program addresses the problem of opioid disorders—including the pervasive misuse of prescription opioids—by providing cutting edge tools to physicians treating patients struggling with opioid addiction,” said SAMHSA Administrator Pamela S. Hyde, JD. “It is another example of how SAMHSA is working with the general health care system to bring addiction medicine into the mainstream.”

The current SAMHSA-funded PCSS is supported by 70 mentors, five clinical experts and a medical director. Its primary target audience includes primary care physicians, pain specialists, psychiatrists and other non-addiction medical practitioners who treat opioid dependent patients and are less familiar with opioid dependence treatment than addictions specialists.  However, addictions specialists will also be encouraged to participate in the PCSS or serve as mentors for physicians desiring to treat opioid dependent patients with buprenorphine products.

This program is part of SAMHSA’s strategic initiative on Behavioral Health Workforce – In Primary and Specialty Care Settings.  The initiative is designed to address workforce development issues affecting the behavioral health and general health service delivery community.
 
This grant it is projected to provide the grantee with up to $500,000 in funding annually for up to three years. Continuation awards are subject to availability of funds and progress achieved by the grantee.

For further information about these grants and other SAMHSA programs, visit http://www.samhsa.gov/.


Leave your comment
 
You must sign in to post
 
Username 
Password 
No Community Member account? Sign up here.
CAPTCHA Validation
Retype the code from the picture
CAPTCHA Code Image
Speak the code Change the code
 

Articles & Archives:
  • Doctors' role in the prescription abuse crisis
  • Out to change attitudes about buprenorphine
  • Landmark recognition for addiction medicine
  • NIDA official: Effective drug treatments for cocaine addiction will surface
  • Maker of Suboxone ramps up patient support
News:
  • Experimental treatments for cocaine addiction may prevent relapse
  • New law requires pharmacies in Massachusetts to carry Rx lock boxes
  • Titan reports patient enrollment in Probuphine study ahead of schedule
  • Purdue Pharma L.P. receives FDA Approval for Butrans (buprenorphine) Transdermal System CIII
  • Partnership to expand initiative on safe use of prescriptions

Current Membership: 701
Quick Contacts

 


© 2010, Vendome Group, LLC. All rights reserved. Privacy Policy.